These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14747387)

  • 1. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable.
    Hoffmann U; Fischereder M; Krüger B; Drobnik W; Krämer BK
    J Am Soc Nephrol; 2004 Feb; 15(2):407-10. PubMed ID: 14747387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
    Merkle M; Sauter M; Argirov M; Wörnle M
    Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points.
    Hoffmann U; Banas B; Fischereder M; Krämer BK
    Kidney Blood Press Res; 2004; 27(3):161-6. PubMed ID: 15256811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity.
    Poletti PA; Saudan P; Platon A; Mermillod B; Sautter AM; Vermeulen B; Sarasin FP; Becker CD; Martin PY
    AJR Am J Roentgenol; 2007 Sep; 189(3):687-92. PubMed ID: 17715118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin C.
    Alioglu E; Saygi S; Turk U; Kirilmaz B; Tuzun N; Duman C; Tengiz I; Yildiz S; Ercan E
    Cardiovasc Ther; 2013 Jun; 31(3):168-73. PubMed ID: 22212518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
    Allaqaband S; Tumuluri R; Malik AM; Gupta A; Volkert P; Shalev Y; Bajwa TK
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
    Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
    G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
    Kimmel M; Butscheid M; Brenner S; Kuhlmann U; Klotz U; Alscher DM
    Nephrol Dial Transplant; 2008 Apr; 23(4):1241-5. PubMed ID: 18174269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
    Chousterman BG; Bouadma L; Moutereau S; Loric S; Alvarez-Gonzalez A; Mekontso-Dessap A; Laissy JP; Rahmouni A; Katsahian S; Brochard L; Schortgen F
    J Crit Care; 2013 Oct; 28(5):701-9. PubMed ID: 23683568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
    Duong MH; MacKenzie TA; Malenka DJ
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):471-9. PubMed ID: 15789388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of N-acetylcysteine on renal function in patients with chronic kidney disease.
    Mainra R; Gallo K; Moist L
    Nephrology (Carlton); 2007 Oct; 12(5):510-3. PubMed ID: 17803476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.
    Baker CS; Wragg A; Kumar S; De Palma R; Baker LR; Knight CJ
    J Am Coll Cardiol; 2003 Jun; 41(12):2114-8. PubMed ID: 12821233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G
    J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-acetylcysteine on radiocontrast nephropathy in rats.
    Yenicerioglu Y; Yilmaz O; Sarioglu S; Ormen M; Akan P; Celik A; Camsari T
    Scand J Urol Nephrol; 2006; 40(1):63-9. PubMed ID: 16452059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcysteine for the prevention of radiocontrast -induced nephropathy.
    Tepel M
    Minerva Cardioangiol; 2003 Oct; 51(5):525-30. PubMed ID: 14551521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acetylcysteine does not artifactually lower plasma creatinine concentration.
    Haase M; Haase-Fielitz A; Ratnaike S; Reade MC; Bagshaw SM; Morgera S; Dragun D; Bellomo R
    Nephrol Dial Transplant; 2008 May; 23(5):1581-7. PubMed ID: 18202091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
    Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
    Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients.
    Rehman T; Fought J; Solomon R
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1610-4. PubMed ID: 18667743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
    Ristikankare A; Kuitunen T; Kuitunen A; Uotila L; Vento A; Suojaranta-Ylinen R; Salmenperä M; Pöyhiä R
    Br J Anaesth; 2006 Nov; 97(5):611-6. PubMed ID: 16914459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial.
    Moist L; Sontrop JM; Gallo K; Mainra R; Cutler M; Freeman D; House AA
    Am J Kidney Dis; 2010 Oct; 56(4):643-50. PubMed ID: 20541301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.